LEADER 04634nam 2200697Ia 450 001 9910785365203321 005 20230725025429.0 010 $a0-470-92277-X 010 $a1-282-88900-1 010 $a9786612889004 010 $a0-470-91091-7 010 $a0-470-91090-9 035 $a(CKB)2670000000056431 035 $a(EBL)698802 035 $a(OCoLC)694941437 035 $a(SSID)ssj0000413548 035 $a(PQKBManifestationID)11319705 035 $a(PQKBTitleCode)TC0000413548 035 $a(PQKBWorkID)10383757 035 $a(PQKB)10681637 035 $a(MiAaPQ)EBC698802 035 $a(Au-PeEL)EBL698802 035 $a(CaPaEBR)ebr10510325 035 $a(CaONFJC)MIL288900 035 $a(EXLCZ)992670000000056431 100 $a20100519d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCardiovascular effects of inhaled ultrafine and nanosized particles$b[electronic resource] /$fedited by Flemming R. Cassee, Nicholas L. Mills, David Newby 210 $aHoboken, N.J. $cJohn Wiley$dc2011 215 $a1 online resource (608 p.) 300 $aDescription based upon print version of record. 311 $a0-470-43353-1 320 $aIncludes bibliographical references and index. 327 $aCARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLES 327 $aCHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS 327 $aCHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS 327 $aPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plate 330 $aThis book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions. 606 $aHeart$xToxicology 606 $aAir$xPollution$xToxicology 606 $aNanoparticles$xToxicology 606 $aPulmonary toxicology 615 0$aHeart$xToxicology. 615 0$aAir$xPollution$xToxicology. 615 0$aNanoparticles$xToxicology. 615 0$aPulmonary toxicology. 676 $a616.1/2071 701 $aCassee$b Flemming R$01563705 701 $aMills$b Nicholas L$01563706 701 $aNewby$b David E$01563707 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910785365203321 996 $aCardiovascular effects of inhaled ultrafine and nanosized particles$93832307 997 $aUNINA